Amanda Gammon

Amanda Gammon, MS, CGC

Languages spoken: English

Academic Information

Departments Adjunct - Population Health Sciences , Midlevel - Huntsman Cancer Institute , Adjunct - Internal Medicine

Divisions: Oncology

Board Certification

  • American Board of Genetic Counseling

Amanda Gammon is a board-certified genetic counselor with a master’s degree in genetic counseling from University of Colorado at Denver Health Sciences Center. She received her bachelor’s degree from the University of Colorado at Boulder in molecular, cellular, and developmental biology and English literature. While completing her education, Amanda worked at Rocky Mountain Cancer Centers. She began working at Huntsman Cancer Institute in July 2007. She provides genetic counseling regarding hereditary cancer risk to patients in the Family Cancer Assessment Clinic. In 2022, she was promoted to Clinical Lead Genetic Counselor to assist with the implementation of new clinical processes and management of the genetic counseling team.

She has also been involved with cancer genetics research, providing genetic counseling for two National Institutes of Health-funded studies, as well as the High Risk Breast Cancer Clinic (a research site of the international Breast Cancer Family Registries). For the FCARE study, she discussed familial colorectal cancer risk with individuals by telephone in rural Utah and Idaho to assess effectiveness of telephone intervention versus written risk information in encouraging individuals to pursue colonoscopy. For the REACH study, she provided hereditary breast and ovarian cancer counseling to women in rural Utah both by phone and in-person to assess equivalency. Her main research interests include hereditary breast cancer, alternative genetic counseling models/methods, and genetics education.

Amanda is highly involved with genetics education. She served as the Assistant Director for the University of Utah Graduate Program in Genetic Counseling (UUGPGC) from 2016-2019. She continues to teach and provide clinical supervision at Huntsman Cancer Institute for UUGPGC students, as well as serve on the curriculum, research oversight, and clinical supervision committees. She also provides teaching or clinical supervision/shadowing for other medical providers, including fellows and DNP students.

Education History

Graduate Training University of Colorado at Denver and Health Sciences
 MS
University of Colorado - Boulder
 BA

Selected Publications

Journal Article

  1. Beigh M, Vagher J, Codden R, Maese LD, Cook S, Gammon A (2024). Newborn Screening for Li-Fraumeni Syndrome: Patient Perspectives. (Read full article)
  2. Baldry E, Baty BJ, Kaphingst KA, Gammon A, Erby LH, Roter DL (2023). Applying the practice-based competencies to evaluate and characterize the contracting process within genetic counseling sessions. J Genet Couns. (Read full article)
  3. Beach WA, Canary HE, Chen YW, Daly BM, Gammon A, Savage MW, Madlensky L, Kaphingst KA (2022). Communication About Negative and Uncertain Results: Interactional Dilemmas During a Genetic Telehealth Consult. Health Commun, 1-12. (Read full article)
  4. Chavez-Yenter D, Goodman MS, Chen Y, Chu X, Bradshaw RL, Lorenz Chambers R, Chan PA, Daly BM, Flynn M, Gammon A, Hess R, Kessler C, Kohlmann WK, Mann DM, Monahan R, Peel S, Kawamoto K, Del Fiol G, Sigireddi M, Buys SS, Ginsburg O, Kaphingst KA (2022). Association of Disparities in Family History and Family Cancer History in the Electronic Health Record With Sex, Race, Hispanic or Latino Ethnicity, and Language Preference in 2 Large US Health Care Systems. JAMA Netw Open, 5(10), e2234574. (Read full article)
  5. Harriman JW, Espinel WF, Vagher J, Gammon A (2022). BRCA1/2 Variants Identified Through Tumor Genomic Profiling: Assessing Genetic Counseling Outcomes. JCO Precis Oncol, 6, e2100375. (Read full article)
  6. Chavez-Yenter D, Kimball KE, Kohlmann W, Lorenz Chambers R, Bradshaw RL, Espinel WF, Flynn M, Gammon A, Goldberg E, Hagerty KJ, Hess R, Kessler C, Monahan R, Temares D, Tobik K, Mann DM, Kawamoto K, Del Fiol G, Buys SS, Ginsburg O, Kaphingst KA (2021). Patient Interactions With an Automated Conversational Agent Delivering Pretest Genetics Education: Descriptive Study. J Med Internet Res, 23(11), e29447. (Read full article)
  7. Kaphingst KA, Kohlmann W, Chambers RL, Goodman MS, Bradshaw R, Chan PA, Chavez-Yenter D, Colonna SV, Espinel WF, Everett JN, Gammon A, Goldberg ER, Gonzalez J, Hagerty KJ, Hess R, Kehoe K, Kessler C, Kimball KE, Loomis S, Martinez TR, Monahan R, Schiffman JD, Temares D, Tobik K, Wetter DW, Mann DM, Kawamoto K, Del Fiol G, Buys SS, Ginsburg O, BRIDGE research team (2021). Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial. BMC Health Serv Res, 21(1), 542. (Read full article)
  8. Nick HP, Kehoe K, Gammon A, Contreras JL, Kaphingst KA (2020). Researcher Knowledge, Attitudes, and Communication Practices for Genomic Data Sharing. J Empir Res Hum Res Ethics, 16(1-2), 125-137. (Read full article)
  9. Moody EW, Vagher J, Espinel W, Goldgar D, Hagerty KJ, Gammon A (2022). Comparison of Somatic and Germline Variant Interpretation in Hereditary Cancer Genes. JCO Precis Oncol, 3, 1-8. (Read full article)
  10. Greenberg S, Buys SS, Edwards SL, Espinel W, Fraser A, Gammon A, Hafen B, Herget KA, Kohlmann W, Roundy C, Sweeney C (2019). Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing. Cancer Med, 8(15), 6789-6798. (Read full article)
  11. Himes DO, Gibbons DK, Birmingham WC, Beckstrand RL, Gammon A, Kinney AY, Clayton MF (2019). Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands. J Genet Couns, 28(5), 950-961. (Read full article)
  12. Young EL, Thompson BA, Neklason DW, Firpo MA, Werner T, Bell R, Berger J, Fraser A, Gammon A, Koptiuch C, Kohlmann WK, Neumayer L, Goldgar DE, Mulvihill SJ, Cannon-Albright LA, Tavtigian SV (2018). Pancreatic cancer as a sentinel for hereditary cancer predisposition. BMC Cancer, 18(1), 697. (Read full article)
  13. Steffen LE, Du R, Gammon A, Mandelblatt JS, Kohlmann WK, Lee JH, Buys SS, Stroup AM, Campo RA, Flores KG, Vicua B, Schwartz MD, Kinney AY (2017). Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode. Cancer Epidemiol Biomarkers Prev, 26(12), 1772-1780. (Read full article)
  14. Patel J, Madan A, Gammon A, Sossenheimer M, Samadder NJ (2017). Rare hereditary cause of chronic pancreatitis in a young male: SPINK1 mutation. Pan Afr Med J, 28, 110. (Read full article)
  15. Flores KG, Steffen LE, McLouth CJ, Vicua BE, Gammon A, Kohlmann W, Vigil L, Dayao ZR, Royce ME, Kinney AY (2016). Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families. J Genet Couns, 26(3), 480-490. (Read full article)
  16. Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J, Brown KL, Sharma L, Saam J, Lancaster J, Daly MB (2017). A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer, 123(10), 1721-1730. (Read full article)
  17. Himes D, Root A, Gammon A, Luthy K (2016). Breast Cancer Risk Assessment: Calculating Lifetime Risk Using the Tyrer-Cuzick Model. 12(9), 581-592.
  18. Kinney AY, Steffen LE, Brumbach BH, Kohlmann W, Du R, Lee JH, Gammon A, Butler K, Buys SS, Stroup AM, Campo RA, Flores KG, Mandelblatt JS, Schwartz MD (2016). Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up. J Clin Oncol, 34(24), 2914-24. (Read full article)
  19. Gammon A, Jasperson K, Champine M (2016). Genetic basis of Cowden syndrome and its implications for clinical practice and risk management. Appl Clin Genet, 9, 83-92. (Read full article)
  20. Young EL, Feng BJ, Stark AW, Damiola F, Durand G, Forey N, Francy TC, Gammon A, Kohlmann WK, Kaphingst KA, McKay-Chopin S, Nguyen-Dumont T, Oliver J, Paquette AM, Pertesi M, Robinot N, Rosenthal JS, Vallee M, Voegele C, Hopper JL, Southey MC, Andrulis IL, John EM, Hashibe M, Gertz J, Breast Cancer Family Registry, Le Calvez-Kelm F, Lesueur F, Goldgar DE, Tavtigian SV (2016). Multigene testing of moderate-risk genes: be mindful of the missense. J Med Genet, 53(6), 366-76. (Read full article)
  21. Chang Y, Near AM, Butler KM, Hoeffken A, Edwards SL, Stroup AM, Kohlmann W, Gammon A, Buys SS, Schwartz MD, Peshkin BN, Kinney AY, Mandelblatt JS, Chang Y, Near AM, Butler KM, Hoeffken A, Edwards SL, Stroup AM, Kohlmann W, Gammon A, Buys SS, Schwartz MD, Peshkin BN, Kinney AY, Mandelblatt JS (2016). Economic Evaluation Alongside a Clinical Trial of Telephone Versus In-Person Genetic Counseling for BRCA1/2 Mutations in Geographically Underserved Areas. J Oncol Pract, 12(1), 59, e1-13. (Read full article)
  22. Gammon A, Neklason DW (2015). Confidentiality & the Risk of Genetic Discrimination: What Surgeons Need to Know. Surg Oncol Clin N Am, 24(4), 667-81. (Read full article)
  23. Kinney AY, Butler KM, Schwartz MD, Mandelblatt JS, Boucher KM, Pappas LM, Gammon A, Kohlmann W, Edwards SL, Stroup AM, Buys SS, Flores KG, Campo RA (2014). Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. J Natl Cancer Inst, 106(12). (Read full article)
  24. Wain KE, Ellingson MS, McDonald J, Gammon A, Roberts M, Pichurin P, Winship I, Riegert-Johnson DL, Weitzel JN, Lindor NM (2014). Appreciating the broad clinical features of SMAD4 mutation carriers: a multicenter chart review. Genet Med, 16(8), 588-93. (Read full article)
  25. Jasperson KW, Kohlmann W, Gammon A, Slack H, Buchmann L, Hunt J, Kirchhoff AC, Baskin H, Shaaban A, Schiffman JD (2013). Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families. Fam Cancer, 13(2), 257-65. (Read full article)
  26. Anderson AE, Flores KG, Boonyasiriwat W, Gammon A, Kohlmann W, Birmingham WC, Schwartz MD, Samadder J, Boucher K, Kinney AY (2014). Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk. Public Health Genomics, 17(1), 48-60. (Read full article)
  27. Gammon A, Jasperson K, Pilarski R, Prior T, Kuwada S (2013). PTEN mosaicism with features of Cowden syndrome. Clin Genet, 84(6), 593-5. (Read full article)
  28. Jasperson KW, Kanth P, Kirchhoff AC, Huismann D, Gammon A, Kohlmann W, Burt RW, Samadder NJ (2013). Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort. Dis Colon Rectum, 56(11), 1211-6. (Read full article)
  29. Rothwell E, Kohlmann W, Jasperson K, Gammon A, Wong B, Kinney A (2011). Patient outcomes associated with group and individual genetic counseling formats. Fam Cancer, 11(1), 97-106. (Read full article)
  30. Valle MP, Francy TC, Judkins MK, Babikyan D, Lesueur F, Gammon A, Goldgar DE, Couch FJ, Tavtigian SV (2011). Classification of missense substitutions in the BRCA genes: a database dedicated to Ex-UVs. Hum Mutat, 33(1), 22-8. (Read full article)
  31. Gammon AD, Rothwell E, Simmons R, Lowery JT, Ballinger L, Hill DA, Boucher KM, Kinney AY (2011). Awareness and preferences regarding BRCA1/2 genetic counseling and testing among Latinas and non-Latina white women at increased risk for hereditary breast and ovarian cancer. J Genet Couns, 20(6), 625-38. (Read full article)
  32. Kinney AY, Gammon A, Coxworth J, Simonsen SE, Arce-Laretta M (2010). Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genet Med, 12(2), 105-15. (Read full article)
  33. Gammon A, Jasperson K, Kohlmann W, Burt RW (2009). Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol, 23(2), 219-31. (Read full article)
  34. Gammon A, Kohlmann W, Burt R (2007). Can we identify the high-risk patients to be screened? A genetic approach. Digestion, 76(1), 7-19. (Read full article)

Review

  1. Vagher J, Gammon A, Kohlmann W, Jeter J (2022). Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders. [Review]. Front Oncol, 12, 837059. (Read full article)

Book Chapter

  1. Colonna S, Gammon A (2016).   Management of the Patient with a Genetic Predisposition for Breast Cancer. In Jatoi I, Rody A (Eds.), Management of Breast Diseases (2nd Edition). Springer International Publishing.